Hyper Corporation

Hyper Corporation Equity Growth

The Year-over-Year Equity Growth of Hyper Corporation (065650.KQ) as of Nov 3, 2026 is -12.20 %. In the previous year, Year-over-Year Equity Growth was -52.60 % — a change of -76.80% (higher).

Equity Growth

-12.20 %

YoY

-76.80%

Last updated:

Year-over-Year Equity Growth of Hyper Corporation is 2025 -12.20 % . Year-over-Year Equity Growth of Hyper Corporation was 2024 -52.60 % . It decreases by -76.80% higher compared to the previous year.

The Hyper Corporation Equity Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Growth
Date
Equity Growth
Jan 1, 2018
-22.44 KRW
Jan 1, 2019
-7.85 KRW
Jan 1, 2020
57.47 KRW
Jan 1, 2021
51.82 KRW
Jan 1, 2022
-26.48 KRW
Jan 1, 2023
18.66 KRW
Jan 1, 2024
-52.60 KRW
Jan 1, 2025
-12.20 KRW
The Hyper Corporation Equity Growth history
YEAREquity GrowthYoY
-12.20 %-76.80%
-52.60 %-381.85%
18.66 %-170.47%
-26.48 %-151.11%
51.82 %-9.84%
57.47 %-832.36%
-7.85 %-65.03%
-22.44 %+597.10%
-3.22 %-143.16%
7.46 %-262.76%
-4.58 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hyper Corporation Stock analysis

What does Hyper Corporation do? Hyper Corporation Inc generates revenue through the Information Technology Business segment, which manufactures and sells mouses, monitors, televisions, routers, and game devices, while also operating Internet portals and specialized sites. The New Drug Business segment develops and sells non narcotic analgesics, Alzheimer's treatments, and Alzheimer's dementia diagnosis kits. The company's IT products are purchased by consumers and businesses seeking technology solutions, while the pharmaceutical products target healthcare providers and patients requiring pain management and cognitive health support. The Information Technology Business segment benefits from the sale of hardware devices and digital content services, with Internet portals and specialized sites driving user engagement and advertising revenue. The New Drug Business segment focuses on medical solutions for chronic conditions, serving both institutional and individual markets through direct sales channels. Both segments operate under the same corporate structure, leveraging the company's existing infrastructure for product development and distribution. Hyper Corporation is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hyper Corporation stock

Year-over-Year Equity Growth of Hyper Corporation is -12.20 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year Equity Growth Hyper Corporation since 2006 – with annual values, charts, and detailed analysis.

Equity growth measures the percentage change in shareholders' equity. It reflects retained earnings, share issuances, and comprehensive income effects.

To evaluate Year-over-Year Equity Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Equity Growth.

Year-over-Year Equity Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Equity Growth's Hyper Corporation historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Hyper Corporation

All Key Metrics — Hyper Corporation